Insider Trading May 13, 2026 09:07 PM

Director Moore Executes Stock Transactions at Texas Roadhouse; Recent Earnings and Analyst Actions Provide Context

Analysis of recent insider sales, alongside Q1 2026 financial results and updated price targets from major investment banks.

By Ajmal Hussain TXRH

Texas Roadhouse director Gregory N. Moore conducted multiple stock transactions on May 11, 2026, including a significant sale through the Moore Family Trust and a gift to a charitable foundation. This activity was reported alongside Texas Roadhouse's mixed Q1 2026 earnings results and subsequent analyst actions. While the company surpassed EPS expectations of $1.87 (vs. $1.82), revenue slightly missed forecasts at $1.63 billion (vs. $1.64 billion). Analysts from Piper Sandler and Stifel adjusted price targets, noting strong same-store sales while also highlighting the need for continued performance to support value positioning.

Director Moore Executes Stock Transactions at Texas Roadhouse; Recent Earnings and Analyst Actions Provide Context
TXRH

Key Points

  • Insider activity by director Gregory N. Moore shows both significant liquidations (selling shares) and philanthropic actions (gifting shares).
  • Texas Roadhouse reported strong profitability, with EPS of $1.87 surpassing the expected $1.82, despite slightly missing revenue forecasts.
  • Multiple analysts raised price targets for TXRH based on strong operational metrics like a 7.1% rise in same-store sales and noted the company's value position.

The recent activities of Texas Roadhouse director Gregory N. Moore provide a clear look at high-level insider movements within the company, occurring against a backdrop of mixed financial reporting and varied analyst commentary.

On May 11, 2026, Mr. Moore executed several transactions involving the common stock of Texas Roadhouse, Inc. (NASDAQ: TXRH). Specifically, he sold 1,250 shares of the company's common stock. These shares were sold at $178.14 per share, resulting in a total sale value of $222,674. The disposition was structured through the Moore Family Trust, where Mr. Moore holds investment control and serves as co-trustee.

It is noteworthy that this sale took place when the stock price was trading at $179.30, reflecting a strong upward trend of 13.5% over the preceding week's trading period. In addition to the sale, Mr. Moore also transferred 1,000 shares of Texas Roadhouse common stock as a bona fide gift. These gifted shares were directed to the Kathleen C. Moore Foundation, a charitable organization classified as a 501(c)(3), for which Mr. Moore serves both as President and Chief Executive Officer.

Following these reported transactions, the current holdings within the structure reflect specific parameters: the Moore Family Trust now holds 29,900 shares of Texas Roadhouse common stock. Furthermore, Mr. Moore maintains a direct holding of 1,700 Restricted Stock Units (RSUs). These RSUs represent conditional rights to receive one share for each unit and are scheduled to vest on January 8, 2027. The delivery of these vested shares is contingent upon Mr. Moore’s continued service with the company.

Financial Performance and Analyst Reaction

These insider actions coincide with Texas Roadhouse’s release of its first-quarter 2026 earnings. The financial report presented a mixed picture for the company. On one hand, Texas Roadhouse achieved an earnings per share (EPS) of $1.87, successfully exceeding analyst expectations which had projected $1.82. This suggests solid profitability relative to market forecasts.

However, the revenue figure presented a slight deviation from projections. The company reported total revenue of $1.63 billion, falling marginally short of the forecasted amount of $1.64 billion. Despite this minor shortfall in top-line growth compared to estimates, the underlying operational strength was highlighted by market analysts.

In response to these results and ongoing performance metrics, major investment banks adjusted their outlooks. Piper Sandler increased its price target for Texas Roadhouse to $192 from a previous level of $190, while maintaining a Neutral rating. The firm cited the company's achievement of a 7.1% rise in same-store sales during the first quarter as evidence of robust operational health. Similarly, Stifel adjusted its price target to $180, up from $170, though they maintained a Hold rating. Both institutions noted that Texas Roadhouse’s success is attributable to its value position and decentralized operating culture.

These varied professional assessments underscore Texas Roadhouse’s demonstrated capacity to maintain strong sales momentum despite the broader challenges facing the industry. Both Piper Sandler and Stifel acknowledged the strategic initiatives undertaken by the company, suggesting these efforts are crucial in supporting its sustained performance.

Investment Context and Valuation

From a technical analysis standpoint, the market's perception of Texas Roadhouse’s valuation remains a point of interest. According to an InvestingPro analysis, the company currently appears overvalued when assessed using Fair Value calculations. This suggests that while operational metrics are strong, some external financial indicators suggest caution regarding current pricing.

The reported stock trading data provides further context: as of recent closing and after-hours trades, TXRH was observed fluctuating around $178 to $179 per share, with a notable 13.5% gain recorded over the prior week's period. These movements illustrate investor attention and potential volatility surrounding corporate developments.

Risks

  • The stock is currently flagged by analysis as appearing overvalued based on Fair Value calculations, which could signal potential downward pressure.
  • Revenue slightly missed analyst projections for Q1 2026 ($1.63 billion vs. $1.64 billion forecast), suggesting potential headwinds in top-line growth.
  • Insider selling activity, such as the sale of 1,250 shares by Mr. Moore, could be interpreted by some investors as a sign of internal concerns or profit-taking.

More from Insider Trading

Insider Selling at Clover Health Amid Mixed Q1 Results May 13, 2026 Mineralys CMO Activity and Company Developments Offer Mixed Signals May 13, 2026 Executive Selling Activity and Strong Q1 Results for Netlist Inc. Under Scrutiny May 13, 2026 Insider Purchases Signal Confidence at Rallybio Amid Strategic Shifts and Clinical Progress May 13, 2026 Insider Activity at Digi International Highlights Recent Transactions and Corporate Developments May 13, 2026